Peptide aptamers: Tools to negatively or positively modulate HSPB1(27) function

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1617, 2013, Pages 1-8

  Gibert, Benjamin ^a   Simon, Stéphanie ^b   Dimitrova, Valeriya ^c   Diaz Latoud, Chantal ^a   Arrigo, André Patrick ^a  

^a UNIVERSITÉ DE LYON   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

B crystallin; Aptamer; HSP27; HSPB1; Oligomerization; Oxidative stress

Indexed keywords

APOPTOSIS; CANCER; DRUG RESISTANCE; INJURY; MOLECULAR ANALYSIS; PATHOLOGY; PEPTIDE; PHYSIOLOGICAL RESPONSE; TUMOR;

CHAPERONE; HEAT SHOCK PROTEIN 27; HSPB1 PROTEIN, HUMAN; PEPTIDE APTAMER;

CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; REVIEW;

APTAMERS, PEPTIDE; GENE EXPRESSION REGULATION; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; PHOSPHORYLATION;

EID: 84875448098     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0075     Document Type: Article

References (52)

1. Landry J, Chretien P, Lambert H, Hickey E, Weber LA. 1989 Heat shock resistance conferred by expression of the human HSP 27 gene in rodent cells. J. Cell Biol. 109, 7-15. (doi:10.1083/jcb.109.1.7)
2. Kampinga HH, Brunsting JF, Stege GJ, Konings AW, Landry J. 1994 Cells overexpressing Hsp27 show accelerated recovery from heat-induced nuclear protein aggregation. Biochem. Biophys. Res. Commun. 204, 1170-1177. (doi:10.1006/bbrc. 1994.2586)
3. Arrigo AP. 2001 Hsp27: novel regulator of intracellular redox state. IUBMB Life 52, 303-307. (doi:10.1080/152165401317291156)
4. Mehlen P, Schulze-Osthoff K, Arrigo AP. 1996 Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J. Biol. Chem. 271, 16510-16514. (doi:10.1074/jbc.271.28.16510)
5. Arrigo AP. 2000 sHSPs as novel regulators of programmed cell death and tumorigenicity. Pathol. Biol. 48, 280-288.
6. Concannon CG, Gorman AM, Samali A. 2003 On the role of Hsp27 in regulating apoptosis. Apoptosis 8, 61-70. (doi:10.1023/A:1021601103096)
7. Huot J, Roy G, Lambert H, Chretien P, Landry J. 1991 Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res. 51, 5245-5252.
8. Lee GJ, Roseman AM, Saibil HR, Vierling E. 1997 A small heat shock protein stably binds heat-denatured model substrates and can maintain a substrate in a folding-competent state. EMBO J. 16, 659-671. (doi:10.1093/emboj/16.3.659)
9. Ehrnsperger M, Graber S, Gaestel M, Buchner J. 1997 Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J. 16, 221-229. (doi:10.1093/emboj/16.2.221)
10. Mehlen P, Préville X, Kretz-Remy C, Arrigo AP. 1996 Human hsp27, Drosophila hsp27 and human αB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these protein against TNFa-induced cell death. EMBO J. 15, 2695-2706.
11. Preville X, Salvemini F, Giraud S, Chaufour S, Paul C, Stepien G, Ursini MV, Arrigo AP. 1999 Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp. Cell Res. 247, 61-78. (doi:10.1006/excr. 1998.4347)
12. Bruey JM et al. 2000 Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2, 645-652. (doi:10.1038/35023595)
13. Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, Arrigo AP. 2002 Hsp27 as a negative regulator of cytochrome C release. Mol. Cell Biol. 22, 816-834. (doi:10.1128/MCB.22.3.816-834.2002)
14. Pandey P, Farber R, Nakazawa A, Kumar S, Bharti A, Nalin C, Weichselbaum R, Kufe D, Kharbanda S. 2000 Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 19, 1975-1981. (doi:10.1038/sj.onc. 1203531)
15. Gibert B et al. 2012 Knock down of heat shock protein 27 (HspB1) induces degradation of several putative client proteins. PLoS ONE 7, e29719. (doi:10.1371/journal.pone.0029719)
16. Charette SJ, Lavoie JN, Lambert H, Landry J. 2000 Inhibition of daxx-mediated apoptosis by heat shock protein 27. Mol. Cell Biol. 20, 7602-7612. (doi:10.1128/MCB.20.20.7602-7612.2000)
17. Wu R, Kausar H, Johnson P, Montoya-Durango DE, Merchant M, Rane MJ. 2007 Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J. Biol. Chem. 282, 21598-21608. (doi:10.1074/ jbc.M611316200)
18. Rocchi P, Beraldi E, Ettinger S, Fazli L, Vessella RL, Nelson C, Gleave M. 2005 Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Res. 65, 11083-11093. (doi:10.1158/0008-5472.CAN-05-1840)
19. Andrieu C et al. 2010 Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. Oncogene 29, 1883-1896. (doi:10.1038/onc.2009.479)
20. Ciocca DR, Calderwood SK. 2005 Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10, 86-103. (doi:10.1379/CSC-99r.1)
21. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. 2006 Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem. Sci. 31, 164-172. (doi:10.1016/j.tibs.2006.01.006)
22. Garrido C, Fromentin A, Bonnotte B, Favre N, Moutet M, Arrigo AP, Mehlen P, Solary E. 1998 Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res. 58, 5495-5499.
23. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. 2006 Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5, 2592-2601. (doi:10.4161/cc.5.22.3448)
24. Lemieux P, Oesterreich S, Lawrence JA, Steeg PS, Hilsenbeck SG, Harvey JM, Fuqua SA. 1997 The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis 17, 113-123.
25. Blackburn RV, Galoforo SS, Berns CM, Armour EP, McEachern D, Corry PM, Lee YJ. 1997 Comparison of tumor growth between Hsp25- and Hsp27-transfected murine L929 cells in nude mice. Int. J. Cancer 72, 871-877. (doi:10.1002/ (SICI)1097-0215(19970904)72:5,871::AID-IJC26.3.0.CO;2-A)
26. Bausero MA, Page DT, Osinaga E, Asea A. 2004 Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol. 25, 243-251. (doi:10. 1159/000081387)
27. Bausero MA et al. 2006 Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell. Tumour Biol. 27, 17-26. (doi:10.1159/000090152)
28. Xu L, Chen S, Bergan RC. 2006 MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 25, 2987-2998. (doi:10.1038/sj. onc.1209337)
29. Fanelli MA, Montt-Guevara M, Diblasi AM, Gago FE, Tello O, Cuello-Carrion FD, Callegari E, Bausero MA, Ciocca DR. 2008 P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. Cell Stress Chaperones 13, 207-220. (doi:10. 1007/s12192-007-0007-z)
30. Paul C, Simon S, Gibert B, Virot S, Manero F, Arrigo AP. 2010 Dynamic processes that reflect anti-apoptotic strategies set up by HspB1 (Hsp27). Exp. Cell Res. 316, 1535-1552. (doi:10.1016/j.yexcr. 2010.03.006)
31. Arrigo AP. 2011 Structure-functions of HspB1 (Hsp27). Methods Mol. Biol. 787, 105-119. (doi:10. 1007/978-1-61779-295-3_9)
32. Aloy MT, Hadchity E, Bionda C, Diaz-Latoud C, Claude L, Rousson R, Arrigo A-P, Rodriguez-Lafrasse C. 2008 Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells. Int. J. Radiat. Oncol. Biol. Phys. 70, 543-553. (doi:10.1016/j.ijrobp. 2007.08.061)
33. Kaur P, Nagaraja GM, Asea A. 2011 Combined lentiviral and RNAi technologies for the delivery and permanent silencing of the hsp25 gene. Methods Mol. Biol. 787, 121-136. (doi:10.1007/978-1-61779-295-3_10)
34. Heinrich JC, Tuukkanen A, Schroeder M, Fahrig T, Fahrig R. 2011 RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients. J. Cancer Res. Clin. Oncol. 137, 1349-1361. (doi:10.1007/ s00432-011-1005-1)
35. Colas P, Cohen B, Jessen T, Grishina I, McCoy J, Brent R. 1996 Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380, 548-550. (doi:10.1038/380548a0)
36. Buerger C, Nagel-Wolfrum K, Kunz C, Wittig I, Butz K, Hoppe-Seyler F, Groner B. 2003 Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells. J. Biol. Chem. 278, 37610-37621. (doi:10.1074/jbc.M301629200)
37. de Chassey B, Mikaelian I, Mathieu AL, Bickle MB, Olivier D, Negre D, Cosset FL, Rudkin BB, Colas P. 2006 An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and upregulates its activity. Mol. Cell Proteomics 4, 4.
38. Chattopadhyay A, Tate SA, Beswick RW, Wagner SD, Ko Ferrigno P. 2006 A peptide aptamer to antagonize BCL-6 function. Oncogene 25, 2223-2233. (doi:10.1038/sj.onc.1209252)
39. Nouvion AL, Thibaut J, Lohez OD, Venet S, Colas P, Gillet G, Lalle P. 2007 Modulation of Nr-13 antideath activity by peptide aptamers. Oncogene 26, 701-710. (doi:10.1038/sj.onc.1209832)
40. Gibert B, Hadchity E, Czekalla A, Aloy MT, Colas P, Rodriguez-Lafrasse C, Arrigo AP, Diaz-Latoud C. 2011 Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers. Oncogene 34, 3672-3681. (doi:10.1038/ onc.2011.73)
41. Bickle MB, Dusserre E, Moncorge O, Bottin H, Colas P. 2006 Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures. Nat. Protocol 1, 1066-1091. (doi:10.1038/nprot.2006.32)
42. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR. 1994 A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78, 1027-1037. (doi:10.1016/0092-8674(94) 90277-1)
43. Zantema A, Vries MV-D, Maasdam D, Bol S, van der Eb A. 1992 Heat shock protein 27 and αB-crystallin can form a complex, which dissociates by heat shock. J. Biol. Chem. 267, 12936-12941.
44. Mehlen P, Préville X, Chareyron P, Briolay J, Klemenz R, Arrigo AP. 1995 Constitutive expression of human hsp27, Drosophila hsp27, or human αB-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J. Immunol. 154, 363-374.
45. Bova MP, Yaron O, Huang Q, Ding L, Haley DA, Stewart PL, Horwitz J. 1999 Mutation R120G in αB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc. Natl Acad. Sci. USA 96, 6137-6142. (doi:10.1073/pnas. 96.11.6137)
46. Simon S, Fontaine JM, Martin JL, Sun X, Hoppe AD, Welsh MJ, Benndorf R, Vicart P. 2007 Myopathy-associated αB-crystallin mutants: abnormal phosphorylation, intracellular location, and interactions with other small heat shock proteins. J. Biol. Chem. 82, 34276-34287. (doi:10.1074/jbc. M703267200)
47. Vicart P et al. 1998 A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 20, 92-95. (doi:10. 1038/1765)
48. Ito H, Kamei K, Iwamoto I, Inaguma Y, Tsuzuki M, Kishikawa M, Shimada A, Hosokawa M, Kato K. 2003 Hsp27 suppresses the formation of inclusion bodies induced by expression of R120G αB-crystallin, a cause of desmin-related myopathy. Cell Mol. Life Sci. 60, 1217-1223.
49. Dimitrova V, Simon S, Gibert B, Virot S, Mounier N, Kretz-Remy C, Mehlen P, Arrigo AP. Submitted. Analysis of the dominant effects mediated by wild-type and R120G mutant of αB-crystallin (HspB5) towards Hsp27 (HspB1).
50. Voorter CE, de Haard-Hoekman WA, Roersma ES, Meyer HE, Bloemendal H, de Jong WW. 1989 The in vivo phosphorylation sites of bovine αB-crystallin. FEBS Lett. 259, 50-52.
51. Simon S, Michiel M, Skouri-Panet F, Lechaire JP, Vicart P, Tardieu A. 2007 Residue R120 is essential for the quaternary structure and functional integrity of human αB-crystallin. Biochemistry 46, 9605-9614. (doi:10.1021/bi7003125)
52. Arrigo AP et al. 2007 Hsp27 (HspB1) and αB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 581, 3665-3674. (doi:10.1016/j.febslet.2007. 04.033)